Is guideline-adherent prescribing associated with quality of life in patients with type 2 diabetes?

Kirsten P J SmitsGrigory SidorenkovNanne KleefstraSteven H HendriksMargriet BoumaMarianne MeulepasGerjan NavisHenk J G BiloPetra Denig

Published in: PloS one (2018)

We found no evidence for associations between guideline-adherent prescribing or disease-specific medication burden and HRQoL in T2D patients. This gives no rise to refrain from prescribing intensive treatment in T2D patients as recommended, but the interpretation of these results is limited by the cross-sectional study design and the selection of patients included in some indicators.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
primary care
cross sectional
prognostic factors
healthcare
emergency department